Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binkui Li

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Surgery|May 11, 2015
Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: A propensity score matching studyJiliang Qiu, Yun Zheng, Jingxian Shen, et al.
European Journal of Gastroenterology & Hepatology|February 2, 2012
Hepatectomy for hepatocellular carcinoma patients with macronodular cirrhosisQing-an Zeng, Jiliang Qiu, Jian Hong, et al.
BMC Cancer|April 19, 2012
Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: a long-term follow-up studyQing-An Zeng, Jiliang Qiu, Ruhai Zou, et al.
Journal for Immunotherapy of Cancer|July 6, 2022
Pathological complete response to immune checkpoint inhibitor in patients with colorectal cancer liver metastases harboring <i>POLE</i> exonuclease domain mutationLei Wen, Zhigang Chen, Xiaomeng Ji, et al.
Cancer Communications (London, England)|September 25, 2024
Partial hepatectomy versus interventional treatment in patients with hepatitis B virus-related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trialYichuan Yuan, Hong Peng, Wei He, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2025
USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinomaYichuan Yuan, Yi Niu, Zhenkun Huang, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 4, 2021
Long-term outcome for colorectal liver metastases: combining hepatectomy with intraoperative ultrasound guided open microwave ablation versus hepatectomy aloneYunzhu Dai, Yuanping Zhang, Wei He, et al.
Cell Death & Disease|August 4, 2022
NXN suppresses metastasis of hepatocellular carcinoma by promoting degradation of Snail through binding to DUB3Yuanping Zhang, Dinglan Zuo, Jiliang Qiu, et al.
Cancer Communications (London, England)|May 23, 2018
Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort studyWei He, Yun Zheng, Ruhai Zou, et al.
Journal of Clinical and Translational Hepatology|August 14, 2023
Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular CarcinomaKeren Li, Yi Niu, Kai Li, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Surgery|May 11, 2015
Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: A propensity score matching studyJiliang Qiu, Yun Zheng, Jingxian Shen, et al.
European Journal of Gastroenterology & Hepatology|February 2, 2012
Hepatectomy for hepatocellular carcinoma patients with macronodular cirrhosisQing-an Zeng, Jiliang Qiu, Jian Hong, et al.
BMC Cancer|April 19, 2012
Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: a long-term follow-up studyQing-An Zeng, Jiliang Qiu, Ruhai Zou, et al.
Journal for Immunotherapy of Cancer|July 6, 2022
Pathological complete response to immune checkpoint inhibitor in patients with colorectal cancer liver metastases harboring <i>POLE</i> exonuclease domain mutationLei Wen, Zhigang Chen, Xiaomeng Ji, et al.
Cancer Communications (London, England)|September 25, 2024
Partial hepatectomy versus interventional treatment in patients with hepatitis B virus-related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trialYichuan Yuan, Hong Peng, Wei He, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2025
USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinomaYichuan Yuan, Yi Niu, Zhenkun Huang, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 4, 2021
Long-term outcome for colorectal liver metastases: combining hepatectomy with intraoperative ultrasound guided open microwave ablation versus hepatectomy aloneYunzhu Dai, Yuanping Zhang, Wei He, et al.
Cell Death & Disease|August 4, 2022
NXN suppresses metastasis of hepatocellular carcinoma by promoting degradation of Snail through binding to DUB3Yuanping Zhang, Dinglan Zuo, Jiliang Qiu, et al.
Cancer Communications (London, England)|May 23, 2018
Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort studyWei He, Yun Zheng, Ruhai Zou, et al.
Journal of Clinical and Translational Hepatology|August 14, 2023
Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular CarcinomaKeren Li, Yi Niu, Kai Li, et al.
Pageof 9